BARRIER REVERSE CONVERTIBLE - PFIZER INC Share Price

Certificat

RPFABV

CH1275374036

Market Closed - Swiss Exchange 16:20:00 10/05/2024 BST
95.3 USD +1.60% Intraday chart for BARRIER REVERSE CONVERTIBLE - PFIZER INC
Current year+11.07%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change Volume
10/05/24 95.3 +1.60% 0
08/05/24 93.8 +0.75% 0
07/05/24 93.1 +1.86% 0

Delayed Quote Swiss Exchange

Last update May 10, 2024 at 04:20 pm

More quotes

Static data

Product typeCertificati Azionari e Obbl.ri
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Vontobel Vontobel
RPFABV
ISINCH1275374036
Date issued 21/07/2023
Strike 37 $
Maturity 22/07/2024 (72 Days)
Parity 0.04 : 1
Emission price 99 $
Emission volume N/A
Settlement entrambi
Currency USD

Technical Indicators

Highest since issue 99.8 $
Lowest since issue 80.7 $

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.01 USD
Average target price
31.94 USD
Spread / Average Target
+14.02%
Consensus
  1. Stock Market
  2. Certificates
  3. RPFABV Certificat